英特集团:公司是浙江省医药流通重点企业

中金财经
Mar 11

  证券之星消息,英特集团(000411)03月11日在投资者关系平台上答复投资者关心的问题。投资者提问:公司近期业绩下滑、经营现金流为负、股价长期低迷,而并购扩张持续推进却未能同步改善盈利与资产回报。请问管理层公司目前在经营模式、资金周转、并购整合与市值管理上均存在结构性问题?针对高负债、低毛利、回款困难及股东回报持续弱化等核心矛盾,是否有明确的量化整改目标和具体落地时间表?同时,未来并购策略是否将从规模扩张转向质量提升,切实改善现金流与股东收益?英特集团回复:您好!公司是浙江省医药流通重点企业,目前经营业绩正常。您所述的各项财务指标均符合行业运行特征,股价表现受宏观经济、行业市场等多重因素综合影响。未来,公司将持续深耕主业,聚焦创新驱动,不断加强核心竞争力,巩固行业地位。感谢您的关注。为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10